These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21292124)

  • 1. Clinical, molecular, and genomic changes in response to a left ventricular assist device.
    Hall JL; Fermin DR; Birks EJ; Barton PJ; Slaughter M; Eckman P; Baba HA; Wohlschlaeger J; Miller LW
    J Am Coll Cardiol; 2011 Feb; 57(6):641-52. PubMed ID: 21292124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects.
    Ambardekar AV; Buttrick PM
    Circ Heart Fail; 2011 Mar; 4(2):224-33. PubMed ID: 21406678
    [No Abstract]   [Full Text] [Related]  

  • 3. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
    Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
    Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular assist device-induced molecular changes in the failing myocardium.
    Soppa GK; Barton PJ; Terracciano CM; Yacoub MH
    Curr Opin Cardiol; 2008 May; 23(3):206-18. PubMed ID: 18382208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist Devices: Results From the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS).
    Topkara VK; Garan AR; Fine B; Godier-Furnémont AF; Breskin A; Cagliostro B; Yuzefpolskaya M; Takeda K; Takayama H; Mancini DM; Naka Y; Colombo PC
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27402861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Implications of Respiratory Failure in Patients Receiving Durable Left Ventricular Assist Devices for End-Stage Heart Failure.
    Miller PE; Caraballo C; Ravindra NG; Mezzacappa C; McCullough M; Gruen J; Levin A; Reinhardt S; Ali A; Desai NR; Ahmad T
    Circ Heart Fail; 2019 Nov; 12(11):e006369. PubMed ID: 31707800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery from heart failure with circulatory assist: a working group of the National, Heart, Lung, and Blood Institute.
    Reinlib L; Abraham W;
    J Card Fail; 2003 Dec; 9(6):459-63. PubMed ID: 14966786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bridge to recovery: what remains to be discovered?
    Ibrahim M; Terracciano CM; Yacoub MH
    Cardiol Clin; 2011 Nov; 29(4):531-47. PubMed ID: 22062202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
    Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
    Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of myocardial beta-adrenergic receptor signaling after left ventricular assist device support.
    Pandalai PK; Bulcao CF; Merrill WH; Akhter SA
    J Thorac Cardiovasc Surg; 2006 May; 131(5):975-80. PubMed ID: 16678578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
    Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
    J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(3):1-60. PubMed ID: 27026798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    J Heart Lung Transplant; 2019 Feb; 38(2):114-126. PubMed ID: 30691593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial.
    Fukushima N; Tatsumi E; Seguchi O; Takewa Y; Hamasaki T; Onda K; Yamamoto H; Hayashi T; Fujita T; Kobayashi J
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):373-379. PubMed ID: 29948739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Congestive heart failure: reverse cardiac remodeling mediated by left ventricular assist devices].
    Wohlschläger J; Milting H; Stypmann J; Hager T; Schmid C; Levkau B; Baba HA
    Pathologe; 2012 May; 33(3):175-82. PubMed ID: 22576594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanical circulatory support therapy as a bridge to transplant or recovery (new advances).
    Kirklin JK; Holman WL
    Curr Opin Cardiol; 2006 Mar; 21(2):120-6. PubMed ID: 16470148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of children implanted with ventricular assist devices in the United States: First analysis of the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS).
    Blume ED; Rosenthal DN; Rossano JW; Baldwin JT; Eghtesady P; Morales DL; Cantor RS; Conway J; Lorts A; Almond CS; Naftel DC; Kirklin JK;
    J Heart Lung Transplant; 2016 May; 35(5):578-84. PubMed ID: 27009673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.